Merck Animal Health
About Merck Animal Health
For over a century, Merck Animal Health has been a global health care leader working to help the world be well. Merck Animal Health, known as MSD outside the United States and Canada, is the global animal health business unit of Merck Animal Health. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets.
13 articles with Merck Animal Health
-
Merck Animal Health Survey Reveals First-Time Dog Owners Need Support
11/23/2020
Merck Animal Health, known as MSD Animal Health outside the US and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced a new survey about first-time dog owners and whether or not they were prepared for pet parenthood.
-
Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day
9/28/2020
In recognition of World Rabies Day on September 28, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies through ongoing dog vaccination efforts.
-
Merck Animal Health Completes Acquisition of IdentiGEN
8/5/2020
Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture
-
Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
7/9/2020
Portfolio Expansion Ensures Dogs and Puppies 8 Weeks of Age and Older Receive Early, Broad-Spectrum Protection Against Fleas and Ticks
-
Merck Animal Health to Acquire U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals
5/13/2020
Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection
-
Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan®
2/19/2020
Elanco Animal Health Incorporated announced it signed an agreement with Merck Animal Health to divest worldwide rights for Vecoxan® for $55 million in an all-cash deal.
-
Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare
12/17/2019
Strategic Transaction Benefits and Improves Aquaculture Health and Performance
-
Merck Animal Health Introduces BRAVECTO® Cares to Show Support for the Health of Service Dogs
5/21/2019
Sponsorship of NEADS World Class Service Dogs Underscores the Importance of Keeping Pets Protected from Fleas and Ticks
-
Merck Animal Health Announces Increase in Funding for Veterinary Student Scholarship Program
11/14/2017
Merck Animal Health has announced an increase of $115,000 in funding for its Veterinary Student Scholarship Program.
-
Merck Animal Health Introduces Care & Control of Pet Diabetes to Help Pet Owners Deal With the Disease
11/7/2017
Merck Animal Health has launched Care & Control of Pet Diabetes Featuring Sugar & Spike, a global educational program to provide pet owners with the tools they need to help manage their pets’ diabetes.
-
Merck Animal Health Extends Commitment To Fighting Rabies In The World’s Most At-Risk Regions
9/28/2017
-
Aurinia Completes Licensing Deal With Merck Animal Health For Its Nanomicellar Formulation Of Voclosporin For The Treatment Of Canine Dry Eye Syndrome
4/18/2017
-
Merck Animal Health Completes Acquisition Of Vallée S.A.
3/23/2017